About Us

Scyntek is a pioneering MedTech company committed to revolutionizing vascular health monitoring through innovative, at-home deep vein thrombosis (DVT) detection. Founded by a team of passionate innovators at the University of North Carolina at Chapel Hill, we blend expertise in biomedical engineering, computer science, and entrepreneurship to develop solutions that empower patients. Our breakthrough system is a non-invasive, at-home early detection system for deep vein thrombosis (DVT). Our goal is to provide accessible, affordable, and efficient solutions that empower individuals to monitor their vascular health, reducing reliance on costly hospital visits and diagnostic procedures.With robust academic partnerships, strategic industry funding, and recognition from prestigious competitions, Scyntek is setting a new standard for accessible, proactive healthcare..